{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:02:58Z","timestamp":1748923378457,"version":"3.41.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mehy.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T15:57:49Z","timestamp":1460303869000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cimetidine as a novel adjunctive treatment for early stage Lyme disease"],"prefix":"10.1016","volume":"128","author":[{"given":"Justin","family":"Shemenski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0005","first-page":"1","article-title":"Surveillance for Lyme disease\u2013United States, 1992\u20132006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveillance Summaries"},{"issue":"9","key":"10.1016\/j.mehy.2016.03.015_b0010","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1 Suppl","key":"10.1016\/j.mehy.2016.03.015_b0015","first-page":"S1","article-title":"Evidence-based guidelines for the management of Lyme disease","volume":"2","author":"Cameron","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07853899909115982","article-title":"Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis","volume":"31","author":"Oksi","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.mehy.2016.03.015_b0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2007.12.011","article-title":"Chronic Lyme disease: a review","volume":"22","author":"Marques","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0030","doi-asserted-by":"crossref","first-page":"e48277","DOI":"10.1371\/journal.pone.0048277","article-title":"Characterization of biofilm formation by Borrelia burgdorferi in vitro","volume":"7","author":"Sapi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2016.03.015_b0035","unstructured":"Sharma B, Brown A, Lewis, K. Persister formation in Borrelia burgdorferi. In: Paper presented at: 114th General Meeting of the American Society of for Microbiology; May 17\u201320, 2014. Boston, MA, USA."},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0040","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/infdis\/167.5.1074","article-title":"Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi","volume":"167","author":"Klempner","year":"1993","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(00)80206-8","article-title":"Antigenic variation in Lyme disease Borreliae by promiscuous recombination of VMP-like sequence cassettes","volume":"89","author":"Zhang","year":"1997","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.mehy.2016.03.015_b0050","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1074\/jbc.M007994200","article-title":"The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi","volume":"276","author":"Hellwage","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.micinf.2003.11.014","article-title":"Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease","volume":"6","author":"Embers","year":"2004","journal-title":"Microbes Infect"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01781096","article-title":"Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants","volume":"24","author":"Preac Mursic","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.mehy.2016.03.015_b0065","first-page":"119","article-title":"Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi","volume":"146","author":"Alban","year":"2000"},{"issue":"8","key":"10.1016\/j.mehy.2016.03.015_b0070","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/IAI.65.8.3100-3106.1997","article-title":"Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H\/HeJ) mice but not in disease-resistant (BALB\/c) mice","volume":"65","author":"Zeidner","year":"1997","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0075","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/jid.2009.202","article-title":"Spitting image: tick saliva assists the causative agent of Lyme disease in evading host skin\u2019s innate immune response","volume":"129","author":"Hovius","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.mehy.2016.03.015_b0080","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jama.2013.278331","article-title":"CDC estimates 300,000 US cases of Lyme disease annually","volume":"310","author":"Kuehn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2016.03.015_b0085","unstructured":"Reported cases of Lyme disease by year, United States, 2002\u20132011. Centers for Disease Control and Prevention Website. <http:\/\/www.cdc.gov\/lyme\/stats\/chartstables\/reportedcases_statelocality.html>. Updated Sept 12, 2012. Accessed Aug 19, 2012."},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2016.03.015_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IDR.S15653","article-title":"Lyme disease: the next decade","volume":"4","author":"Stricker","year":"2011","journal-title":"Infect Drug Resistance"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0100","first-page":"184","article-title":"Histamine type-2 receptor antagonist immune modulation. I. Increased cell-mediated cytotoxicity in normal and in down-regulated systems","volume":"103","author":"Gifford","year":"1988","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/IAI.69.2.687-694.2001","article-title":"Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients","volume":"69","author":"Diterich","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.mehy.2016.03.015_b0110","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/654809","article-title":"Final report of the Lyme disease review panel of the Infectious Diseases Society of America","volume":"51","author":"Lantos","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006454-198804000-00010","article-title":"Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy","volume":"7","author":"Weber","year":"1988","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/158.4.905","article-title":"Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis","volume":"158","author":"Schmidli","year":"1988","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajcp\/91.1.95","article-title":"Spirochetes in the spleen of a patient with chronic Lyme disease","volume":"91","author":"Cimmino","year":"1989","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.mehy.2016.03.015_b0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01645543","article-title":"Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis","volume":"17","author":"Preac-Mursic","year":"1989","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/163.2.311","article-title":"Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis","volume":"163","author":"Pfister","year":"1991","journal-title":"Infect Dis"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01710737","article-title":"Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings","volume":"21","author":"Strle","year":"1993","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0150","first-page":"155","article-title":"First isolation of Borrelia burgdorferi from an iris biopsy","volume":"13","author":"Preac-Mursic","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"issue":"11","key":"10.1016\/j.mehy.2016.03.015_b0155","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/art.1780361118","article-title":"Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis","volume":"36","author":"Haupl","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01780661","article-title":"Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans","volume":"24","author":"Strle","year":"1996","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01780643","article-title":"Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis","volume":"24","author":"Preac-Mursic","year":"1996","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.mehy.2016.03.015_b0170","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/brain\/119.6.2143","article-title":"Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature","volume":"119","author":"Oksi","year":"1996","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/ard.57.2.118","article-title":"Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy","volume":"57","author":"Priem","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2133.2001.04034.x","article-title":"Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus","volume":"144","author":"Breier","year":"2001","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0185","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/AAC.49.4.1294-1301.2005","article-title":"In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy","volume":"49","author":"Hunfeld","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5694\/j.1326-5377.1998.tb141415.x","article-title":"Culture-positive Lyme borreliosis","volume":"168","author":"Hudson","year":"1998","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/art.1780310405","article-title":"Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue","volume":"31","author":"Steere","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"18","key":"10.1016\/j.mehy.2016.03.015_b0200","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1001\/jama.1988.03720180063034","article-title":"Fatal adult respiratory distress syndrome in a patient with Lyme disease","volume":"259","author":"Kirsch","year":"1988","journal-title":"JAMA"},{"issue":"2 pt 2","key":"10.1016\/j.mehy.2016.03.015_b0205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0190-9622(93)70043-S","article-title":"Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection","volume":"28","author":"Liegner","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mehy.2016.03.015_b0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00003086-199312000-00038","article-title":"Chronic septic arthritis caused by Borrelia burgdorferi","volume":"297","author":"Battafarano","year":"1993","journal-title":"Clin Orthopaedics"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-5347(17)35989-X","article-title":"Urinary dysfunction in Lyme disease","volume":"149","author":"Chancellor","year":"1993","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.mehy.2016.03.015_b0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.mehy.2016.03.015_b0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00019048-199405000-00016","article-title":"Spirochetemia after continuous high-dose oral amoxicillin therapy","volume":"3","author":"Masters","year":"1994","journal-title":"Infect Dis Clin Practice"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000117104","article-title":"Seronegative chronic relapsing neuroborreliosis","volume":"35","author":"Lawrence","year":"1995","journal-title":"Eur Neurol"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01716077","article-title":"Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases","volume":"24","author":"Bayer","year":"1996","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0245","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/174.3.623","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis","volume":"174","author":"Nocton","year":"1996","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0250","doi-asserted-by":"crossref","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of Borrelia burgdorferi in Rhesus macaques following antibiotic treatment of disseminated infection","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0255","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"year":"2007","series-title":"Microbiology: a human perspective","author":"Nester","key":"10.1016\/j.mehy.2016.03.015_b0260"},{"year":"2009","series-title":"The immune system","author":"Parham","key":"10.1016\/j.mehy.2016.03.015_b0265"},{"key":"10.1016\/j.mehy.2016.03.015_b0270","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.coi.2015.03.007","article-title":"Regulation of human helper T cell subset differentiation by cytokines","volume":"34","author":"Schmitt","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.mehy.2016.03.015_b0275","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.mehy.2016.03.015_b0280","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.mehy.2016.03.015_b0285","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/intimm\/10.8.1017","article-title":"Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4","volume":"10","author":"Liu","year":"1998","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0290","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.4049\/jimmunol.172.10.6427","article-title":"Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10","volume":"172","author":"Skapenko","year":"2004","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0295","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by TH1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2016.03.015_b0300","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0020-7519(99)00042-9","article-title":"Tick modulation of host immunity: an important factor in pathogen transmission","volume":"29","author":"Wikel","year":"1999","journal-title":"Int J Parasitol"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/173.1.187","article-title":"Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma","volume":"173","author":"Zeidner","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0310","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1645\/GE-1416.1","article-title":"Suppression of TH2 cytokines reduces tick-transmitted Borrelia burgdorferi load in mice","volume":"94","author":"Zeidner","year":"2008","journal-title":"J Parasitol"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0315","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.179.3.1497","article-title":"Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva","volume":"179","author":"S\u00e1-nunes","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0320","doi-asserted-by":"crossref","first-page":"e18220","DOI":"10.1371\/journal.pone.0018220","article-title":"Decreased TH1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans","volume":"6","author":"Sj\u00f6wall","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2249.2005.02820.x","article-title":"Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes","volume":"141","author":"Sj\u00f6wall","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0330","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1086\/382893","article-title":"Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome","volume":"189","author":"Widhe","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00330-07","article-title":"Lyme arthritis: current concepts and a change in paradigm","volume":"15","author":"Nardelli","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2016.03.015_b0340","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1128\/IAI.66.6.2691-2697.1998","article-title":"Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys","volume":"66","author":"Giambartolomei","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/art.1780400111","article-title":"T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines","volume":"40","author":"Yin","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.mehy.2016.03.015_b0350","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1128\/IAI.71.7.3979-3987.2003","article-title":"Borrelia burgdorferi- induced tolerance as a model of persistence via immunosuppression","volume":"71","author":"Diterich","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0355","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1128\/IAI.67.10.5142-5150.1999","article-title":"Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense","volume":"67","author":"Brown","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2567.2002.01500.x","article-title":"Cytokines in Lyme borreliosis: lack of early tumor necrosis factor-alpha and transforming growth factor-beta-1 responses are associated with chronic neuroborreliosis","volume":"107","author":"Widhe","year":"2002","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0365","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1086\/513873","article-title":"Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4weeks after ceftriaxone treatment in C3H\/He mice","volume":"195","author":"Yrj\u00e4n\u00e4inen","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.2007.03474.x","article-title":"Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H\/HeN mice","volume":"150","author":"Ekerfelt","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.mehy.2016.03.015_b0375","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.4049\/jimmunol.164.12.6096","article-title":"Cutting edge: T cell-mediated pathology in murine Lyme borreliosis","volume":"164","author":"Mckisic","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0380","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.154.4.1770","article-title":"T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice","volume":"154","author":"Keane-myers","year":"1995","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0385","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.160.2.1022","article-title":"T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis","volume":"160","author":"Gross","year":"1998","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0390","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/intimm\/dxh304","article-title":"Up-regulation of Borrelia-specific IL-4- and IFN-y-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis","volume":"17","author":"Widhe","year":"2005","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0395","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2249.2006.03245.x","article-title":"Decreased up regulation of the interleukin-12 R beta @-chain and interferon gamma secretion and increased number of forkhead box P3- expressing cells in patients with history of chronic Lyme borreliosis compared to asymptomatic Borrelia exposed individuals","volume":"147","author":"Jarefors","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"5609","key":"10.1016\/j.mehy.2016.03.015_b0400","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0405","first-page":"573","article-title":"Developments, pharmacology, and efficacy","volume":"97","author":"Freston","year":"1982"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejps.2011.02.004","article-title":"Cimetidine: an anticancer drug?","volume":"42","author":"Kubecova","year":"2011","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0415","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-5728(89)90011-8","article-title":"Cimetidine as an immunomodulator in the treatment of herpes zoster","volume":"22","author":"Miller","year":"1989","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.mehy.2016.03.015_b0420","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/106002808702101008","article-title":"Effect of cimetidine on herpes zoster infection","volume":"21","author":"Bense","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D33S15Q645","article-title":"Cimetidine: a review of the recent developments and reports in cutaneous medicine","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatol Online J"},{"issue":"29\u201330","key":"10.1016\/j.mehy.2016.03.015_b0430","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1016\/j.vaccine.2011.03.091","article-title":"Cimetidine augments TH1\/TH2 dual polarized immune responses to recombinant HBV antigens","volume":"29","author":"Zhang","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0435","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.exppara.2011.05.012","article-title":"Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum","volume":"128","author":"Li","year":"2011","journal-title":"Exp Parasitol"},{"issue":"4050","key":"10.1016\/j.mehy.2016.03.015_b0440","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.177.4050.707","article-title":"Receptors for histamine can be detected on the surface of selected leukocytes","volume":"177","author":"Melmon","year":"1972","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mehy.2016.03.015_b0445","doi-asserted-by":"crossref","first-page":"120S","DOI":"10.1002\/j.1875-9114.1987.tb03536.x","article-title":"Immunologic effects of cimetidine: Potential uses","volume":"7","author":"Mavligit","year":"1987","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0450","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/106002809002400316","article-title":"Cimetidine: an immunomodulator","volume":"24","author":"Kumar","year":"1990","journal-title":"DICP"},{"issue":"9","key":"10.1016\/j.mehy.2016.03.015_b0455","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4049\/jimmunol.138.9.2760","article-title":"Inhibition of suppressor T lymphocytes (Ts) by cimetidine","volume":"138","author":"Sahasrabudhe","year":"1987","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.mehy.2016.03.015_b0460","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1567-5769(02)00235-7","article-title":"Effects of histamine on TH1\/TH2 cytokine balance","volume":"3","author":"Packard","year":"2003","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0465","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.4049\/jimmunol.161.5.2586","article-title":"Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors","volume":"161","author":"Elenkov","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0470","first-page":"445","article-title":"Cimetidine treatment for viral warts enhances IL-2 and IFN-gamma expression but not IL-18 expression in lesional skin","volume":"13","author":"Mitsuishi","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0475","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2008.04.191","article-title":"Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells","volume":"372","author":"Wang","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0480","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0277-5379(88)90247-7","article-title":"Clinical improvement in advanced cancer disease after treatment combining histamine and H2 histaminics (ranitidine or cimetidine)","volume":"24","author":"Burtin","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0485","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000007686","article-title":"Does cimetidine improve prospects for cancer patients? A reappraisal of the evidence to date","volume":"60","author":"Siegers","year":"1999","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.mehy.2016.03.015_b0490","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1399-6576.1992.tb03452.x","article-title":"Effects of anaesthesia and surgery on the immune response","volume":"36","author":"Salo","year":"1992","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"10.1016\/j.mehy.2016.03.015_b0495","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1445-2197.1994.tb04562.x","article-title":"Cimetidine preserves non-specific immune function after colonic resection for cancer","volume":"64","author":"Adams","year":"1994","journal-title":"Aust NZ J Surg"},{"issue":"5","key":"10.1016\/j.mehy.2016.03.015_b0500","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood.V93.5.1782","article-title":"Cimetidine activates interleukin-12, which enhances cellular immunity","volume":"93","author":"Ishikura","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mehy.2016.03.015_b0505","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-5223(98)70132-1","article-title":"Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass","volume":"116","author":"Katoh","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.mehy.2016.03.015_b0510","doi-asserted-by":"crossref","first-page":"e93243","DOI":"10.1371\/journal.pone.0093243","article-title":"Serum inflammatory mediators as markers of human Lyme disease activity","volume":"9","author":"Soloski","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.mehy.2016.03.015_b0515","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(00)00316-3","article-title":"Decreased CD57 lymphocyte subset in patients with chronic Lyme disease","volume":"76","author":"Stricker","year":"2001","journal-title":"Immunol Lett"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771630007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771630007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:42:42Z","timestamp":1748860962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771630007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":103,"alternative-id":["S030698771630007X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.03.015","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cimetidine as a novel adjunctive treatment for early stage Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}